About Mitochondrial DNA depletion syndrome, encephalomyopathic form with methylmalonic aciduria
Mitochondrial DNA depletion syndrome, encephalomyopathic form with methylmalonic aciduria is a rare disease catalogued by Orphanet (ORPHA:1933). It is associated with the SUCLA2 gene. Search below for active recruiting clinical trials from ClinicalTrials.gov, or visit the Orphanet expert page for specialist centres, natural history studies, and patient registries.
Clinical Trial Eligibility Tips
What to know before applying to Mitochondrial DNA depletion syndrome, encephalomyopathic form with methylmalonic aciduria trials.
Search ClinicalTrials.gov for "Mitochondrial DNA depletion syndrome, encephalomyopathic form with methylmalonic aciduria" or filter by Orphanet code ORPHA:1933 to find disease-specific studies.
Ask your specialist to refer you to a Centre of Expertise — Orphanet lists all accredited centres for this condition worldwide.
Natural history studies and patient registries often enrol before drug trials open — contact the Orphanet patient community first.
Patient Resources
Find recruiting Mitochondrial DNA depletion syndrome, encephalomyopathic form with methylmalonic aciduria trials
Search 500,000+ studies from ClinicalTrials.gov, filtered for Mitochondrial DNA depletion syndrome, encephalomyopathic form with methylmalonic aciduria. Updated daily.